Navigation Links
Over 600 Surgeons Certified to use TruFUSE(R) to Treat Back Pain Sufferers
Date:11/27/2007

Study Indicates 90%+ Success Rate...

CLEARWATER, Fla., Nov. 27 /PRNewswire/ -- minSURG Corporation, a wholly- owned subsidiary of Orthopedic Development Corporation, announced today that it has certified over 600 surgeons in its TruFUSE spine fusion technique.

Over 400 spine surgeons were trained in the basic technique at the North American Spine Society (NASS) convention in Austin, TX last month.

"We believe that this milestone is a reasonable predictor that TruFUSE has the potential to achieve broad acceptance as an early stage surgical solution for back pain sufferers," said James Doulgeris, minSURG's president and CEO.

To support the increase in surgeon users, minSURG has added 21 new domestic regional spine distributors with over 300 additional sales representatives as of today, providing almost complete coverage in the U.S.

"We believe that refinements in the technique and instrumentation provide reliable results with minimum risk and recovery time for patients. That, in conjunction with excellent results from our first study prompted us to release TruFUSE for general distribution in the U.S.," Doulgeris continued.

The TruFUSE minimally invasive back pain alternative uses two small cork- shaped dowels, called allografts, made from human bone, to stop painful spinal facet joints from moving. The dowels are inserted with minimally invasive, minimally destructive techniques between facet joints in the back to stop movement and pain. The TruFUSE technique fills the large void between traditional non-surgical pain management and major surgery.

A retrospective chart review of 81 patients was performed revealing good to excellent pain relief in more than 90% of patients at six weeks postoperatively. Fewer than 5% of patients following up at three months continued to complain of severe pain. The most frequently encountered complication relates to dowel migration, which was observed in 8.6% of patients. Only one of the seven migration cases required revision surgery for recurrence of back pain. There were no serious complications noted.

TruFUSE represents a new surgical option for many back pain sufferers who do not yet qualify for major surgery. It may be used to treat a variety of back problems, including augmentation of other procedures for any location from C2-C3 to L5-S1. Compared to many existing methods, TruFUSE is generally less invasive, less destructive, less complicated, less expensive and subjects the patients to relatively minimal risk.

TruFUSE has been used on select patients since March 2006, and went into limited distribution in August 2006.

For more information on TruFUSE, please visit the Web site at http://www.trufuse.com or call (813) 318-0565 ext. 216.


'/>"/>
SOURCE minSURG Corporation
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. MedHelp to Add Top Stanford Surgeons and Specialized Forums to Online Health Community
2. Surgeons Remove Gallbladder Through Vagina
3. CRH Medical to exhibit at American College of Surgeons Annual Clinical Congress
4. Cosmetic Surgeons Gather in Dubai for World Congress, Hospital Opening
5. Starion Instruments Launches Next-Generation Tissue Ligating Shears at the American College of Surgeons Clinical Congress
6. Patients should ask surgeons about using honey to heal wounds
7. Expert Neurosurgeons and Neuro-oncologists to Speak at 6th Annual Brain Tumor Awareness Day Convention
8. Survey shows gender differences are factor when surgeons in training choose a subspecialty
9. American College of Surgeons Comments on JAMA Article on Surgeon Shortage
10. Holiday Hand Safety 101: Hand Surgeons Offer Tips for a Safe Carving Season
11. Verdict One Releases Directory of Board Certified Attorneys for Consumers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... TherapySites, ... its affiliation with Tennessee Counseling Association. This new relationship allows TherapySites ... Tennessee Counseling Association, adding exclusive benefits and promotional offers. , "TCA is extremely ...
(Date:6/26/2016)... ... ... Quality metrics are proliferating in cancer care, and are derived from many of ... beholder, according to experts who offered insights and commentary in the current issue of ... full issue, click here . , For the American Society of Clinical Oncology ...
(Date:6/26/2016)... ... ... Brent Kasmer, a legally blind and certified personal trainer is helping to develop a weight ... app plans to fix the two major problems leading the fitness industry today:, ... program , They don’t eliminate all the reasons people quit their exercise program ...
(Date:6/25/2016)... ... ... Bruton Memorial Library on June 21 due to a possible lice infestation, as reported by ... lice: the parasite’s ability to live away from a human host, and to infest common ... the event that lice have simply gotten out of control. , As lice are a ...
(Date:6/25/2016)... Oklahoma City, Oklahoma (PRWEB) , ... June 25, ... ... to helping both athletes and non-athletes recover from injury. Recently, he has implemented ... for the Oklahoma City area —Johnson is one of the first doctors to ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... June 24, 2016  Arkis BioSciences, a leading ... and more durable cerebrospinal fluid treatments, today announced ... Series-A funding is led by Innova Memphis, followed ... other private investors.  Arkis, new financing will accelerate ... the market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... BEVERLY HILLS, Calif. , June 23, 2016 ... faced the many challenges of the current process. Many of ... option because of the technical difficulties and high laboratory costs ... would have to offer it at such a high cost ... to afford it. Dr. Parsa Zadeh , ...
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that it ... (procalcitonin) assay as a dedicated testing solution for people ... Roche is the first IVD company in the U.S ... assessment and management. PCT is a sepsis-specific ... blood can aid clinicians in assessing the risk of ...
Breaking Medicine Technology: